Virtual Meeting: Innovative Solutions to Provider Qualification Challenges
Recorded Monday, April 6, 2020
With the rapidly evolving changes in clinical research being driven by the COVID-19 pandemic, now, more than ever, it is essential to engage with your colleagues on proven solutions to challenges. The objectives of this virtual meeting were to discuss the following:
|
|
Includes a Q&A session with:
![]() |
Patty Leuchten Founder and CEO The Avoca Group |
![]() |
Brian Whitlock VP, Head of Global Procurement R&D Bristol-Myers Squibb |
This virtual meeting is ideally suited for industry leaders and executives who oversee provider qualification activities and those in the following roles:
- Clinical Operations
- Vendor Oversight
- Procurement
- Quality Management
*The Diligent® Qualification Platform is one approach the industry can take to reduce variability, costs, and cycle times while improving the quality of vendor qualification information to ensure compliance and establish an initial baseline assessment supporting vendor risk management efforts. Diligent’s RFI Database of Vendors includes categories that enable and support adaptive approaches, such as home nursing/monitoring, eCOA, and eConsent.
If you’d like more information about how Diligent can help your organization, contact us.